Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Dose-Ranging Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) in Acute Ischemic Stroke
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007211/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of the study is to assess the clinical effects of natalizumab versus
placebo in acute ischemic stroke on clinical measures of functional independence and
activities of daily living. The secondary objective of the study is to explore dose and
exposure response and the clinical treatment effects of natalizumab versus placebo in acute
ischemic stroke on the following: measures of independence, activities of daily living,
neurologic function, quality of life, cognition, and safety and tolerability
提供机构：
Vivli
创建时间：
2021-06-10
